These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 23414863

  • 1. Gene alterations and intestinal mucosal changes following growth factor and omega-3 exposure in a rat model of inflammatory bowel disease.
    Katz MS, Thatch KA, Schwartz MZ.
    J Pediatr Surg; 2013 Feb; 48(2):345-52. PubMed ID: 23414863
    [Abstract] [Full Text] [Related]

  • 2. Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease.
    Katz MS, Thatch KA, Schwartz MZ.
    J Pediatr Surg; 2012 Jan; 47(1):194-8. PubMed ID: 22244416
    [Abstract] [Full Text] [Related]

  • 3. Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease.
    Thatch KA, Mendelson KG, Haber MM, Schwartz MZ.
    J Surg Res; 2009 Oct; 156(2):245-9. PubMed ID: 19524260
    [Abstract] [Full Text] [Related]

  • 4. Chronology of the effect of massive small bowel resection and hepatocyte growth factor (HGF) on intestinal adaptation.
    Katz MS, Thatch KA, Schwartz MZ.
    J Surg Res; 2011 Dec; 171(2):399-403. PubMed ID: 21658720
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease.
    Arthur LG, Schwartz MZ, Kuenzler KA, Birbe R.
    J Pediatr Surg; 2004 Feb; 39(2):139-43; discussion 139-43. PubMed ID: 14966727
    [Abstract] [Full Text] [Related]

  • 6. Is OM-3 synergistic with GLP-2 in intestinal failure?
    Karmaker A, Costanzo CM, Schwartz MZ.
    J Surg Res; 2017 Jan; 207():7-12. PubMed ID: 27979490
    [Abstract] [Full Text] [Related]

  • 7. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.
    Alavi K, Schwartz MZ, Palazzo JP, Prasad R.
    J Pediatr Surg; 2000 Jun; 35(6):847-51. PubMed ID: 10873024
    [Abstract] [Full Text] [Related]

  • 8. Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo.
    Kato Y, Yu D, Lukish JR, Schwartz MZ.
    J Surg Res; 1997 Jul 15; 71(1):49-53. PubMed ID: 9271277
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte growth factor increases glucagon immunoreactivity in jejunal cells during intestinal adaptation.
    Timmapuri SJ, Otterburn DM, Arafat H, Schwartz MZ.
    J Pediatr Surg; 2006 Jan 15; 41(1):150-4; discussion 150-4. PubMed ID: 16410125
    [Abstract] [Full Text] [Related]

  • 10. [Effect of hepatocyte growth factor on intestinal permeability and bacterial translocation after small bowel transplantation in rat].
    Li K, Li N, Li J.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May 15; 21(5):532-5. PubMed ID: 17578297
    [Abstract] [Full Text] [Related]

  • 11. Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis.
    Setoyama H, Ido A, Numata M, Moriuchi A, Yamaji N, Tamai T, Funakawa K, Fujita H, Sakiyama T, Uto H, Oketani M, Tsubouchi H.
    Life Sci; 2011 Aug 15; 89(7-8):269-75. PubMed ID: 21763320
    [Abstract] [Full Text] [Related]

  • 12. The effect of hepatocyte growth factor on gene transcription during intestinal adaptation.
    Katz MS, Thatch KA, Schwartz MZ.
    J Pediatr Surg; 2011 Feb 15; 46(2):357-65. PubMed ID: 21292088
    [Abstract] [Full Text] [Related]

  • 13. The satiety factor apolipoprotein A-IV modulates intestinal epithelial permeability through its interaction with alpha-catenin: implications for inflammatory bowel diseases.
    Orsó E, Moehle C, Boettcher A, Szakszon K, Werner T, Langmann T, Liebisch G, Buechler C, Ritter M, Kronenberg F, Dieplinger H, Bornstein SR, Stremmel W, Schmitz G.
    Horm Metab Res; 2007 Aug 15; 39(8):601-11. PubMed ID: 17712726
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats.
    Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T, Hayashi K, Tsubouchi H.
    J Pharmacol Exp Ther; 2003 Oct 15; 307(1):146-51. PubMed ID: 12954797
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor ameliorates mucosal injuries leading to inhibition of colon cancer development in mice.
    Yamaji N, Ido A, Moriuchi A, Numata M, Setoyama H, Tamai T, Funakawa K, Fujita H, Sakiyama T, Uto H, Oketani M, Tsubouchi H.
    Oncol Rep; 2011 Aug 15; 26(2):335-41. PubMed ID: 21567095
    [Abstract] [Full Text] [Related]

  • 16. Effects of hepatocyte growth factor on rat inflammatory bowel disease models.
    Ohda Y, Hori K, Tomita T, Hida N, Kosaka T, Fukuda Y, Miwa H, Matsumoto T.
    Dig Dis Sci; 2005 May 15; 50(5):914-21. PubMed ID: 15906768
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of colonic inflammation by partial replacement of dietary linoleic acid with α-linolenic acid in a rat model of inflammatory bowel disease.
    Tyagi A, Kumar U, Reddy S, Santosh VS, Mohammed SB, Ehtesham NZ, Ibrahim A.
    Br J Nutr; 2012 Nov 14; 108(9):1612-22. PubMed ID: 22243775
    [Abstract] [Full Text] [Related]

  • 18. Enteral glutamine does not enhance the effects of hepatocyte growth factor in short bowel syndrome.
    Alavi K, Kato Y, Yu D, Schwartz MZ.
    J Pediatr Surg; 1998 Nov 14; 33(11):1666-9. PubMed ID: 9856891
    [Abstract] [Full Text] [Related]

  • 19. Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets.
    Roy N, Barnett M, Knoch B, Dommels Y, McNabb W.
    Mutat Res; 2007 Sep 01; 622(1-2):103-16. PubMed ID: 17574631
    [Abstract] [Full Text] [Related]

  • 20. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease.
    Ido A, Numata M, Kodama M, Tsubouchi H.
    J Gastroenterol; 2005 Oct 01; 40(10):925-31. PubMed ID: 16261428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.